# Brady Corp: Form 10-Q for the period ended Apr 30, 2015

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2015-05-27
- Accepted by EDGAR: May 27, 2015, 12:58 ET
- Period: 2015-04-30
- Accession: 0000746598-15-000084
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659815000084/brc-20150430x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659815000084/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-04-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-02-01 to 2015-04-30 | $290.2m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2014-08-01 to 2015-04-30 | $883.1m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2015-02-01 to 2015-04-30 | $149.2m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-08-01 to 2015-04-30 | $453.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-02-01 to 2015-04-30 | $141.0m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-08-01 to 2015-04-30 | $429.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-02-01 to 2015-04-30 | $8.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2014-08-01 to 2015-04-30 | $27.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2015-02-01 to 2015-04-30 | $103.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-08-01 to 2015-04-30 | $319.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-02-01 to 2015-04-30 | $24.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-08-01 to 2015-04-30 | $68.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-02-01 to 2015-04-30 | $2.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-08-01 to 2015-04-30 | $8.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-02-01 to 2015-04-30 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-08-01 to 2015-04-30 | $16.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-02-01 to 2015-04-30 | $17.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-08-01 to 2015-04-30 | $42.4m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2015-02-01 to 2015-04-30 | 51,450,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-08-01 to 2015-04-30 | 51,370,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-08-01 to 2015-04-30 | $52.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2014-08-01 to 2015-04-30 | $23.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2014-08-01 to 2015-04-30 | $30.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2014-08-01 to 2015-04-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-04-30 | $100.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-04-30 | $416.3m | us-gaap:AssetsCurrent |
| Total assets | at 2015-04-30 | $1.14bn | us-gaap:Assets |
| Current liabilities | at 2015-04-30 | $207.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-04-30 | $488.0m | us-gaap:Liabilities |
| Long-term debt | at 2015-04-30 | $213.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-04-30 | $42.5m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2015-04-30 | $654.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/746598/000074659815000084/brc-20150430x10q.htm

Filed May 27, 2015.
Source: SEC EDGAR, the filing index for accession 0000746598-15-000084. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
